Our study also further supports that risk factors associated with marginal donors, aging, hypertension, and a history of stroke could further sustain fractalkine-mediated endothelial activation, leucocyte recruitment and impact transplant vascular injury and repair (32). The gene discussed is CX3CL1; the disease is stroke disorder.